Overview and Chemical Properties

1-BOC-1,2,3,4-Tetrahydroquinoline-6-boronic acid (Aladdin SKU: B180748) is an arylboronic acid derivative featuring a partially saturated bicyclic tetrahydroquinoline scaffold with a tert-butoxycarbonyl (BOC) protecting group on the ring nitrogen and a boronic acid (–B(OH)₂) substituent at the 6-position of the aromatic ring.

The BOC group serves a dual purpose: it protects the secondary amine from unwanted side reactions during synthetic manipulations and modulates the electronic and steric environment of the molecule. The boronic acid moiety is the reactive handle for carbon–carbon bond-forming reactions, most notably the Suzuki–Miyaura cross-coupling. The tetrahydroquinoline core is a privileged scaffold in medicinal chemistry, appearing in numerous bioactive natural products and drug candidates.

Boronic acids are known to be mildly air- and moisture-sensitive due to their propensity to form boroxines (anhydrides) under dehydrating conditions or to undergo protodeboronation. Proper handling and storage are therefore essential to preserve reagent integrity.

Safety and Handling

Personal Protective Equipment (PPE): Always wear nitrile gloves, safety goggles, and a laboratory coat when handling this compound. Work in a well-ventilated fume hood.

Moisture and Air Sensitivity: Although not classified as pyrophoric, boronic acids can slowly absorb moisture from the air, leading to partial hydrolysis or boroxine formation. Upon receipt, inspect the material and reseal under nitrogen or argon if possible. Store in a desiccator over silica gel or molecular sieves when long-term storage is required.

BOC Group Stability: The BOC protecting group is stable under neutral and mildly basic conditions but is cleaved rapidly by strong acids (e.g., trifluoroacetic acid, HCl in dioxane) or by thermolysis at elevated temperatures. Avoid exposing solutions of this compound to strong acidic conditions unless BOC removal is the intended transformation.

First Aid: In case of skin contact, wash thoroughly with soap and water. In case of eye contact, rinse with copious amounts of water for at least 15 minutes and seek medical attention. Consult the Safety Data Sheet (SDS) for complete hazard information.

Review flag: Specific GHS hazard classifications and R/S phrases for this compound should be confirmed from the official Aladdin SDS for B180748 before use.

Protocol: Suzuki–Miyaura Cross-Coupling

The following is a general procedure for Suzuki–Miyaura cross-coupling using 1-BOC-1,2,3,4-Tetrahydroquinoline-6-boronic acid as the boronic acid partner. Optimize conditions for your specific aryl/heteroaryl halide substrate.

Materials Required

• 1-BOC-1,2,3,4-Tetrahydroquinoline-6-boronic acid (B180748), 1.0–1.5 equivalents
• Aryl or heteroaryl halide (electrophilic coupling partner), 1.0 equivalent
• Palladium catalyst (e.g., Pd(PPh₃)₄ or Pd(dppf)Cl₂), 2–5 mol%
• Inorganic base (e.g., K₂CO₃, Cs₂CO₃, or Na₂CO₃), 2–3 equivalents
• Solvent system: DMF/H₂O (4:1), dioxane/H₂O (4:1), or THF/H₂O (4:1)
• Inert gas supply (N₂ or Ar)
• Schlenk flask or sealed vial

Procedure

1. Charge a dry Schlenk flask with the aryl halide (1.0 eq), 1-BOC-1,2,3,4-Tetrahydroquinoline-6-boronic acid (B180748, 1.2 eq), and the palladium catalyst (2–5 mol%).
2. Add the inorganic base (2.5 eq) and the solvent mixture. Seal the flask.
3. Degas the reaction mixture by three freeze–pump–thaw cycles or by sparging with inert gas for 15 minutes.
4. Heat the reaction at 80–100 °C with stirring for 12–24 hours under an inert atmosphere. Monitor reaction progress by TLC or LC-MS.
5. Upon completion, cool to room temperature. Dilute with ethyl acetate and wash with water and brine.
6. Dry the organic layer over anhydrous Na₂SO₄, filter, and concentrate under reduced pressure.
7. Purify the crude product by column chromatography (silica gel, appropriate eluent system).

Note: Reaction time, temperature, catalyst loading, and base should be optimized for each substrate. BOC deprotection of the product can be achieved subsequently using standard acidic conditions (e.g., TFA in DCM or 4 M HCl in dioxane) if the free amine is desired.

Troubleshooting and Optimization Tips

Low Conversion: If starting material is observed after the standard reaction time, consider increasing catalyst loading (up to 10 mol%), switching to a more active palladium source (e.g., Pd₂(dba)₃ with SPhos ligand), or raising the reaction temperature incrementally.

Protodeboronation: Boronic acids, particularly electron-rich ones such as this tetrahydroquinoline derivative, are susceptible to protodeboronation under aqueous basic conditions at elevated temperatures. To minimize this, reduce the amount of water in the solvent system, lower the reaction temperature, or use Cs₂CO₃ as a milder base alternative. Adding the boronic acid portionwise or using a microwave reactor for shorter reaction times may also help.

BOC Cleavage During Reaction: Prolonged heating in acidic aqueous conditions can cause partial BOC deprotection. Use neutral or mildly basic aqueous co-solvents and avoid acidic additives to preserve the protecting group integrity.

Incomplete Purification: Biaryl products and the tetrahydroquinoline core may co-elute with palladium-black residues. Treatment of the crude mixture with activated charcoal or use of scavenger resins (e.g., SiliaMetS Thiol) prior to column chromatography can reduce palladium contamination in the final product.

Analytical Confirmation: Confirm product identity and purity by ¹H NMR, ¹³C NMR, and high-resolution mass spectrometry (HRMS). The BOC group typically appears as a singlet near δ 1.45–1.50 ppm (9H) in CDCl₃.

Applications in Drug Discovery and Medicinal Chemistry

The tetrahydroquinoline scaffold is a well-recognized privileged structure in medicinal chemistry. It is found in alkaloids and has been incorporated into numerous drug candidates targeting a variety of biological pathways, including G-protein-coupled receptors (GPCRs), kinases, and ion channels.

1-BOC-1,2,3,4-Tetrahydroquinoline-6-boronic acid (B180748) enables the rapid assembly of 6-arylated or 6-heteroarylated tetrahydroquinoline libraries via Suzuki–Miyaura coupling. Following coupling, the BOC group can be selectively removed to reveal the free secondary amine, which can then be further functionalized (e.g., acylation, sulfonylation, reductive amination) to generate diverse compound collections for biological screening.

Beyond Suzuki coupling, the boronic acid functionality is amenable to Chan–Lam coupling (C–N, C–O bond formation), oxidative transformations (e.g., conversion to phenol via Oxone oxidation), and use as a pharmacophore in boron-containing drugs or as a handle for bioconjugation and affinity chromatography applications.

This compound is particularly attractive for fragment-based drug discovery (FBDD) and high-throughput medicinal chemistry due to the synthetic versatility conferred by the combination of the boronic acid and BOC-protected amine functional groups on a drug-like saturated heterocyclic core.